Edgewise Therapeutics, Inc.
NASDAQ:EWTX
25.28 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 41.666 | 86.097 | 351.947 | 280.789 | 104.916 | 23.653 |
| Short Term Investments
| 428.504 | 232.296 | 329.954 | 265.223 | 24.178 | 0 |
| Cash and Short Term Investments
| 470.17 | 318.393 | 351.947 | 280.789 | 129.094 | 23.653 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 5.313 | 8.604 | 10.104 | 5.968 | 0.551 | 0.39 |
| Total Current Assets
| 475.483 | 326.997 | 351.947 | 280.789 | 129.645 | 24.043 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 11.072 | 12.69 | 9.851 | 0.912 | 0.516 | 0.498 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.262 | 0.348 | 5.303 | 3.532 | 0.975 | 0 |
| Total Non-Current Assets
| 11.334 | 13.038 | 15.154 | 4.444 | 1.491 | 0.498 |
| Total Assets
| 486.817 | 340.035 | 367.101 | 285.233 | 131.136 | 24.541 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 5.579 | 4.025 | 6.105 | 3.843 | 1.58 | 0.667 |
| Short Term Debt
| 0.996 | 0.98 | 1.216 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 17.285 | 11.766 | 9.264 | 6.678 | 2.762 | 0.465 |
| Total Current Liabilities
| 23.86 | 16.771 | 16.585 | 10.521 | 4.342 | 1.132 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 3.741 | 4.434 | 3.8 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0.329 | 0 | 0 |
| Total Non-Current Liabilities
| 3.741 | 4.434 | 3.8 | 0.329 | 160.214 | 40.262 |
| Total Liabilities
| 27.601 | 21.205 | 20.385 | 10.85 | 164.556 | 41.394 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 285.233 | 0.16 | 0.04 |
| Common Stock
| 0.009 | 0.007 | 0.006 | 0.005 | 0 | 0 |
| Retained Earnings
| -378.576 | -244.763 | -144.6 | -76.96 | -34.147 | -17.024 |
| Accumulated Other Comprehensive Income/Loss
| 0.42 | 0.099 | -1.355 | -0.514 | 0 | 0 |
| Other Total Stockholders Equity
| 837.363 | 563.487 | 492.665 | 351.852 | 0.727 | 0.171 |
| Total Shareholders Equity
| 459.216 | 318.83 | 346.716 | 274.383 | -33.42 | -16.853 |
| Total Equity
| 459.216 | 318.83 | 346.716 | 274.383 | -33.42 | -16.853 |
| Total Liabilities & Shareholders Equity
| 486.817 | 340.035 | 367.101 | 285.233 | 131.136 | 24.541 |